The present study was designed to investigate the involvement of the renal nerve in glucocorticoid hyp rtension and to assess the role of the renin-angiotensin system in dexamethasone-induced hypertension.
Although the pathogenesis of glucocorticoid-induced hypertension still remains unclear (Dlakos et al., 1978 ; Elijovich and Krakoff, 1980 ; Krakoff and Bamsel, 1975) , the participation of the renin-angiotensin system has been demonstrated Suzuki et al., 1982 . Indeed, offered the strongest evidence regarding the role of the reninangiotensin system in glucocorticoid hypertension in rats. In their studies, plasma renin activity was increased and the administration of saralasin decreased blood pressure.
Recently Suzuki et al. (1982) also demonstrated a renin-angiotensin dependency in glucocorticoid-hypertensive rats, even though they had been maintained on a normal sodium diet.
The release of renin from the kidney has been shown to be largely mediated by three mechanisms, that is, the intrarenal vascular receptor (baroreceptor) which senses changes in renal perfusion pressure, the macula densa mechanism and the renal nerves (Davis and Freeman, 1976; Reid et al., 1978) . The renal sympathetic nerves can affect control of the renal vasculature and influence renin release (Reid et al., 1978; Schrier, 1974; Torretti, 1982) . Osborn et al. (1981 Osborn et al. ( , 1982 have recently demonstrated that very low-level direct stimulation of the renal nerves in dogs increases renin secretion without inducing any change in renal blood flow, glomerular perfusion pressure.
Thus, although the renal sympathetic activity was strongly involved in renin secretion, the contributory role of the renal nerve to the renin-angiotensin system in hypertension of Cushing's syndrome or glucocorticoid induced hypertension still remains unclear.
Indeed, although the importance of the renal nerves has been well documented in DOCA-salt hypertensive rats (Katholi et al., 1980; Katholi et al., 1983) , little has been reported as to the role of the renal nerve in the development or maintenance of glucocorticoid-hypertension. Therefore, this study was designed to investigate the involvement of the renal nerve in glucocorticoid-hypertension and to assess the role of the renin-angiotensin system in dexamethasone induced hypertension. 
Renal Denervation
To examine the effect of renal denervation on dexamethasone (DEX) induced hypertension, the male SD rats were subjected to bilateral renal denervation (RND) or sham-operation (SHAM) at 8 weeks of age. Under pentobarbital sodium (50mg/kg i.p.) anesthesia, in RND both kidneys were exposed through flank incision, and the renal nerve and connective tissue were stripped away surgically from the renal artery and swabbed with 95% ethanol followed by the application of a string soaked in 10% phenol around the vessel for 10min. In SHAM both kidneys were exposed in the same way, but nerves, blood vessels, and perirenal tissue were left untouched.
Observations were made 4 days after surgery. Analytical Method PRA and PRC were measured by radioimmunoassay of angiotensin I generation by the method of Poulsen and Jorgensen (1974) . Renal norepinephrine content was measured by high performance liquid chromatography (Anton and Sayre, 1962) . The sodium concentration in urine was determined by flame photometry. The Creatinine concentrations in urine and blood were determined by Jaffe's method (Chasson et al., 1961 PRC or PRA of RND without DEX administration compared to SHAM (Table 1) . Although DEX administration significantly increased PRC and PRA of SHAM, RND significantly abolished the increases (Table  1) .
When angiotensin I converting enzyme inhibitior, captopril, was administered, mean blood pressure significantly and dosedependently decreased in SHAM treated with dexamethasone (Fig, 2) .
On the other hand, in vehicle administered rats, whether they were sham operated or renal denervated, captopril caused no significant decrease in blood pressure. On the other hand, RND significantly attenuated the decrease in mean blood pressure due to captopril in rats treated with DEX (p < 0.05, as compared with SHAM with DEX administration, Fig. 2) .
Administration of dexamethasone caused a marked reduction in body weight and significant increases in urine volume, urinary sodium excretion and hematocrit in both RND and S HAM, showing similar changes in all of the variable in both (Table 2 ).
Discussion
Although the exact mechanism of glucocorticoid hypertension still remains unkown a renin-angiotensin dependency has been suggested by several investigators Suzuki et al., 1982) . In our experiments, evidence that the plasma renin concentration and activity were increased and a dose-dependent decrease in blood pressure with angiotensin I converting enzyme inhibition was observed in these dexamethasone induced hypertensive rats, indicates renin-angiotensin dependency.
The dose-dependent decrease in blood pressure with angiotensin I converting enzyme inhibition in glucocorticoidhypertensive rats has already been reported (Suzuki et al., 1982 administration, glucocorticoids were reported to suppress the kallikrein-kinin system (Bonner et al,, 1981; Saruta et al., 1986) and, in addition, the decrease in blood It is well known that an excess amount of glucocorticoid causes sodium depletion in rat (De Bermudez and Hayslett, 1972; Popovtzer et al., 1973) . In our experiment too, dexamethasone treatment resulted in almost doubling of the urine volume, signiand hematocrit, and a marked decrease in body weight, indicating that treatment with an excess amount of dexamethasone caused volume depletion in these rats. The volume depletion should facilitate the activation of the renin-angiotensin system and the sympathetic nerve system through the baroreflex (Aisenbrey et al., 1981; Andrews and Brenner, 1981; Burnier et al., 1983 
